Read again. It is not a Phase2a trial. It is better than that with no waiting as a Phase1/2 Cohort 2a that will produce the same data NOW with no waiting interim.
Medical Professional experts know this.
"This new efficacy Cohort 2a 100K trial is an unprecedented acceleration introduced by the regulatory authorities based on Phase1/2 observed safety and unexpected efficacy results for Cohorts1(50K) & 2 (100K) in both the DAMD and SMD clinical trials."
News 
Market Data 
Discover 
